Clinical notice: This article is for clinician education and workflow support only. It does not replace clinical judgment, institutional policy, or manufacturer instructions for use (IFUs). Prioritize individual assessment (e.g., perfusion/ischemia risk, infection signs, pain, and skin integrity) and escalate per local protocols when concerns arise.
Published: 2026-03-24
Last updated: 2026-03-24
Next clinical review: 2027-03-24
Pressure injury prevention and treatment succeed when two things come together: sound fundamentals (risk assessment, repositioning, support surfaces, moisture and nutrition) and site‑appropriate dressings that protect skin and manage fluid without impeding care. This guide focuses on how to use anatomically shaped sacral and heel silicone foam dressings to: 1) protect intact but at‑risk skin in high‑risk inpatients (Stage I/at‑risk), and 2) manage moderate–high exudate in Stage II–III pressure injuries at the sacrum and heels—while integrating with offloading and routine skin assessments.
You’ll find guideline-aligned recommendations, practical application tips for sacral geometry and heel-cup fit, and a short checklist you can use in ICU, orthopedics, and long-term care.
What current guidelines and evidence say
International guidance recognizes prophylactic polyurethane/multilayer silicone foam dressings as an adjunct to standard prevention at high‑risk anatomical sites such as the sacrum and heels. (Evidence type: international guideline recommendations.) See the International Guideline access pages from EPUAP/NPIAP/PPPIA for the full 2019 Clinical Practice Guideline and Quick Reference Guide, with a 4th edition in progress: the EPUAP guideline portal is here: Pressure ulcer/injury guidelines and downloads (EPUAP) and the overview from NPIAP is here: International Guideline summary (NPIAP). A public prevention bullet specific to heels underscores that dressings do not replace offloading; use heel devices and, where appropriate, foam on high‑risk heels: see NPIAP Prevention Points.
Randomized trials and meta‑analyses suggest that prophylactic multilayer silicone foam reduces hospital‑acquired pressure injury incidence, with the strongest and most consistent prevention signal at sacral sites. (Evidence type: RCTs + meta-analyses; limitation: heel subgroup results are less consistent across studies.) A recent synthesis reported significant sacral risk reduction for stage II+ endpoints: sacral‑focused meta‑analysis (Xia, 2024). ICU and mixed‑ward RCTs have shown benefits when foam is added to prevention bundles, including studies with change intervals around 3 days: examples include Santamaria et al., ICU prophylaxis trial and El Genedy et al., cost‑effectiveness RCT. In high‑moisture risk cohorts (e.g., severe diarrhea), sacrococcygeal ulcers were fewer with prophylactic soft silicone foam: Oe et al., 2020. Heel effects are more variable across studies; always pair any heel dressing with offloading. (Limitation reminder: do not infer heel efficacy from sacral-focused outcomes.)
Treatment once an ulcer exists follows wound characteristics rather than “prophylaxis.” For a concise, guideline‑aligned overview of staging and care principles, see the AAFP 2023 clinical review of pressure injuries.
How sacral and heel silicone foam dressings help
Multilayer silicone foams help at sacral and heel sites by cushioning shear, supporting microclimate control, and maintaining a reliable seal on complex contours. Medical-grade silicone is designed for atraumatic removal, which can reduce skin stripping and discomfort when frequent checks are needed.
If you want a quick refresher on foam dressing structure and indications, review this primer: what foam dressings are and when to use them (SLK Medical explainer).
Sacrum: prophylaxis on intact, at‑risk skin
When to apply
Consider a sacral prophylactic silicone foam when the sacrum/coccyx is at high risk due to immobility, moisture (incontinence, diarrhea), reduced perfusion, or poor nutrition—especially in ICU, peri‑operative, and LTC settings. Use it as an adjunct to repositioning, support surfaces, moisture/incontinence care, and nutrition. Avoid covering unassessed dermatitis, suspected deep tissue injury where frequent inspection is critical, or skin that cannot be kept dry enough to maintain a seal.
Placement and geometry pearls
Anatomically shaped sacral foams are designed to conform across the gluteal cleft and resist edge rolling. Think of the geometry as a map that “bridges” the cleft while smoothing tension at the margins.
Prepare skin: cleanse, pat dry, and avoid emollients immediately before application.
Size and alignment: choose a size that extends beyond the at‑risk zone; align the center over the cleft so the wings lay flat on buttocks without creases.
Edge security: smooth from center out; ensure beveled edges lie flush to reduce shear catch points; replace if edges lift or moisture undermines the seal.
Change the dressing if it is soiled, displaced, wrinkled, or if moisture tracks to the edge. In ICU trials, change intervals of roughly 3 days were feasible; some instructions for use allow longer wear if the skin remains intact and the seal is uncompromised. Representative clinical resources include manufacturer IFUs and practice quick guides used in trials.
Heel: prophylaxis must partner with offloading
When to apply
Use thin, conformable silicone foam on heels at high risk (immobile, neuropathy, vascular disease), but never as a substitute for offloading. Heel‑suspension boots, pillows, or devices that remove calcaneal pressure remain the primary intervention, with dressing as a skin‑protective adjunct. Public guidance from NPIAP underscores this priority: Prevention Points—use heel offloading devices.
3D heel‑cup fit and device compatibility
A 3D heel‑cup silicone foam can sit smoothly over the calcaneus and around the malleoli/Achilles if applied without creases. Confirm that the dressing does not add bulk that compromises an offloading boot’s fit. After application, re‑fit the boot and reassess skin with each turn.
Practical cues:
Select a profile that permits a crease‑free wrap; avoid tight angles around the Achilles.
Secure gently if needed with soft fixation that does not add focal pressure.
At each repositioning, check for edge lift, moisture, or device‑related pressure points.
Stage II–III moderate–high exudate at sacrum or heel
Selection framework for exudate control and edge protection
For open Stage II–III lesions with moderate to heavy exudate, use anatomically shaped bordered silicone foam for absorbency, cushioning, and edge protection. If leakage risk is high (gluteal cleft/malleoli) or saturation is rapid, step up to higher-capacity foam or pair a high-absorbency primary (e.g., alginate) under a silicone border—then change based on strike-through, seal failure, or primary saturation. Related background: managing heavy exudate and wear-time ranges, silicone foam vs hydrocolloid—how to choose, and alginate dressings overview and product page.
When to consider antimicrobial silver foam
Short‑term antimicrobial (e.g., silver‑containing) foam may be appropriate when there are clinical signs of critical colonization or local infection, used alongside debridement and antimicrobial stewardship. Routine or prolonged silver use in clean, healing pressure injuries is discouraged due to limited added benefit and potential cytotoxicity, so reassess frequently and discontinue when bioburden is controlled. For balanced reviews, see a 2024 antimicrobial dressing overview and “Silver in wound care—friend or foe?”.
Absorbency tiers and typical wear‑time ranges (class‑level)
Below is a class‑level snapshot to guide conversations; always follow local policy and individual IFUs.
Dressing class (bordered) | Typical exudate level | Typical wear‑time range when intact skin tolerated and seal maintained |
|---|---|---|
Standard multilayer silicone foam (sacral/heel shapes) | Moderate | Up to ~3 days in ICU routines; up to 5–7 days in some IFUs if no soiling/edge lift |
Silicone foam with superabsorbent core | Moderate–high | Similar or slightly longer than standard if saturation remains below strike‑through; monitor cleft and malleoli closely |
Silicone foam over high‑absorbency primary (e.g., alginate) | High | Change based on primary saturation; border may stay longer if seal and skin assessment permit |
Departmental pathways and economics
A pragmatic prevention/treatment pathway typically looks like this: admission skin check → risk stratification (e.g., Braden) → standard prevention bundle (repositioning schedule, support surface, moisture/incontinence care, nutrition) → consider prophylactic sacral and heel silicone foam dressings on at‑risk intact skin when criteria are met → document daily skin checks and change triggers → reassess at each turn and after any soiling or device adjustment.
Evidence suggests these dressings can be integrated without disrupting routine care, with many trials using 3‑day change intervals unless soiled or displaced. Economic analyses indicate potential value when prevention reduces downstream treatment costs, though findings are setting‑dependent. For examples, see El Genedy et al., ICU cost‑effectiveness RCT (2020) and Padula et al., multi‑hospital cohort value analysis (2017). Remember that institutional policies vary; align with your Tissue Viability team and quality leaders.
In practice, vendors provide anatomically shaped sacral and heel options across absorbency tiers. For example, SLK Medical offers silicone foam dressings in sacral and heel forms, with variants (including silver and higher‑capacity options) that can be selected to match exudate level and fit. This mention is provided for context only; rely on local formulary and IFUs.
Troubleshooting and safety notes
Quick bedside checklist
Change early if: soiling/contamination; edge lift/wrinkling/displacement; strike-through/leakage; new pain/erythema/maceration or device marks; or heel-boot fit is affected.
Document each turn: skin/periwound + moisture exposure; offloading/device status; reason for change and next review time.
Edge lift and rolling at the sacrum typically reflect moisture or tension. Dry the skin thoroughly, avoid pre‑application emollients, select the right size/shape, and smooth from the cleft outward. If exudate tracks to the border, change the dressing and reassess absorbency tier.
At the heel, any dressing is secondary to offloading. Re‑fit boots after application, avoid creases around the Achilles, and ensure no added bulk creates new pressure points. For staging and treatment caveats—including the common question of dry, stable heel eschar—see the guideline‑aligned overview: AAFP’s 2023 pressure injury review. In dry, adherent heel eschar without signs of infection or ischemia, debridement is generally avoided; protect and monitor while prioritizing vascular assessment and offloading.
Document skin integrity at every turn, and teach teams to change dressings immediately if soiled, displaced, wrinkled, or if the seal is compromised. Build prompts into hand‑offs and EHR checklists so inspections aren’t skipped when a dressing is in place.
Putting it all together—practical next steps
Align your unit policy to International Guideline principles for adjunctive prophylactic foam at the sacrum/heels (with heel offloading non-negotiable), and keep the official access pages bookmarked: EPUAP guideline portal and NPIAP International Guideline overview.
Then standardize two things: (1) a simple admission-to-daily-review pathway (screen → criteria → change triggers → documentation) and (2) bedside application competency for sacral geometry and heel-cup fit. Audit process measures (seal integrity, timely changes, offloading compliance) rather than promising outcome rates.
For additional background on dressings and exudate control, the linked explainers above can help orient new staff.
References cited in text (selected)
International Guideline access: EPUAP guideline portal and NPIAP International Guideline overview
Evidence snapshot: Xia 2024 sacral-focused meta-analysis
Clinical overview: AAFP 2023 pressure injury review
